Pharmalex Nordic ApS — Credit Rating and Financial Key Figures
CVR number: 37541540
Agern Alle 24, 2970 Hørsholm
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 2 607.65 | 3 352.25 | 3 282.69 | 2 786.18 | 4 083.05 |
Employee benefit expenses | -2 924.76 | -3 148.48 | -2 967.40 | -3 021.01 | -6 330.30 |
EBIT | - 317.11 | 203.77 | 315.29 | - 234.84 | -2 247.25 |
Other financial income | 21.53 | 0.29 | |||
Other financial expenses | -1 466.01 | -1 231.02 | -5 270.38 | -9 247.39 | -14 153.77 |
Net income from associates (fin.) | 4 996.85 | 5 721.90 | 5 375.77 | 13 802.49 | -74 526.44 |
Pre-tax profit | 3 213.73 | 4 716.18 | 420.68 | 4 320.55 | -90 927.46 |
Income taxes | 390.14 | 221.27 | 984.24 | 1 918.56 | 2 479.80 |
Net earnings | 3 603.87 | 4 937.45 | 1 404.92 | 6 239.12 | -88 447.65 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Holdings in group member companies | 57 327.19 | 57 327.19 | 268 782.60 | 268 856.49 | 188 856.49 |
Investments total | 57 327.19 | 57 327.19 | 268 782.60 | 268 856.49 | 188 856.49 |
Long term receivables total | |||||
Inventories total | |||||
Current amounts owed by group member comp. | 80.84 | 1 278.25 | 192.51 | 370.98 | 381.55 |
Prepayments and accrued income | 0.84 | 0.84 | 865.29 | 768.46 | 636.83 |
Current other receivables | 10.71 | ||||
Current deferred tax assets | 436.14 | 219.25 | 3 047.41 | 4 726.98 | |
Short term receivables total | 517.82 | 1 289.80 | 1 277.05 | 4 186.84 | 5 745.35 |
Cash and bank deposits | 822.35 | 299.81 | 6 251.48 | 612.64 | 779.62 |
Cash and cash equivalents | 822.35 | 299.81 | 6 251.48 | 612.64 | 779.62 |
Balance sheet total (assets) | 58 667.36 | 58 916.80 | 276 311.13 | 273 655.98 | 195 381.46 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 186.68 | 186.68 | 186.68 | 186.68 | 186.68 |
Shares repurchased | 8 000.00 | ||||
Retained earnings | 16 408.38 | 28 012.25 | 32 949.70 | 34 354.62 | 40 593.73 |
Profit of the financial year | 3 603.87 | 4 937.45 | 1 404.92 | 6 239.12 | -88 447.65 |
Shareholders equity total | 28 198.93 | 33 136.38 | 34 541.30 | 40 780.42 | -47 667.24 |
Provisions | 18 591.25 | ||||
Non-current owed to group member | 22 113.01 | 20 944.79 | 182 885.22 | 223 925.81 | 230 061.15 |
Non-current liabilities total | 22 113.01 | 20 944.79 | 182 885.22 | 223 925.81 | 230 061.15 |
Current loans from credit institutions | 30 917.50 | 4 500.00 | 7 700.00 | ||
Current trade creditors | 21.78 | 12.60 | 13.20 | 26.82 | 20.01 |
Current owed to group member | 6 842.40 | 3 376.24 | 8 838.81 | 3 279.31 | 2 059.26 |
Short-term deferred tax liabilities | 543.72 | ||||
Other non-interest bearing current liabilities | 1 491.25 | 903.06 | 523.85 | 1 143.62 | 3 208.28 |
Current liabilities total | 8 355.43 | 4 835.63 | 40 293.36 | 8 949.75 | 12 987.55 |
Balance sheet total (liabilities) | 58 667.36 | 58 916.80 | 276 311.13 | 273 655.98 | 195 381.46 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.